Linkage Tool for the Sepsis Research Network Initiative: List of interested individuals
Notice
IMPORTANT: We invite you to complete this short survey. Once complete, your information will be added to the table below to facilitate collaborations.
The information is provided in the language in which it was submitted by the respondent.
The table below shows information about researchers, individuals and organizations interested in sharing information and/or forging collaborations in relation to the Team Grant: Sepsis Research Network.
The information was provided on a voluntary basis and in no way confers any advantages in the evaluation and funding of applications.
The information is provided in the language in which it was submitted by the respondent.
The table will be updated weekly, until the full application deadline (September 26, 2019).
| Contact information Name Phone Number (optional) Province/Territory Website Address |
Institution/Organization | Focus Areas | Current Position | Additional Information |
|---|---|---|---|---|
| Joseph Ting jting2@cw.bc.ca 604-875-2345 British Columbia Dr. Joseph Ting – BC Children’s Hospital |
University of British Columbia |
|
Clinical Investigator & Clinical Associate Professor | Dr. Ting is also the site investigator for the Canadian Neonatal Network at the British Columbia Women’s Hospital. Conducting collaborative research is one of his many passions in hopes of enhancing neonatal-prenatal health. |
| Cheryl Peters cheryl.peters@cw.bc.ca 778-981-9478 | BC Children’s Hospital |
|
Anesthesiologist and Critical Care | I am interested mostly in prevention, detection and management of sepsis. |
| John Marshall marshallj@smh.ca 416-864-5225 Ontario inFACT |
St. Michael's Hospital/CCCTG/InFACT |
|
Professor of Surgery | I lead an international collaboration of investigator-led trials groups known as the International Forum for Acute Care Trialists (InFACT); InFACT is developing an international initiative on the staging and stratification of critical illness. I also lead a CIHR-funded basic research program on neutrophils in sepsis, and a CIHR-funded clinical research program that seeks to develop a novel and cost-effective model for clinical trials - the platform trial - as a means to support collaborative clinical research through the Canadian Critical Care Trials Group. I am a past-chair of the International Sepsis Forum, and a member of the executive of the Global Sepsis Alliance. |
| Alison Fox-Robichaud afoxrob@mcmaster.ca 9058705801 Ontario Alison Fox-Robichaud Biography |
McMaster University |
|
Professor Medicine | I have started an application as NPA, I have the support of the CCCTG, CCCTBG, have engaged PERC, CAEP members in sepsis and working on engaging the Diabetes Canada. I have made contacts across Canada to engage most known sepsis scientists and intensivists that would be interested in being part of the team. I am also the current president of the Canadian Sepsis Foundation a NFP that is working to advocate for sepsis in Canada. We have also been working with the Sepsis Patients Facebook group, who will be providing patient partners. I have engaged diabetes and population health scientists. We have contacts with our group would value connections to nutrition scientists and any other individuals who would be interested in studying patients with sepsis. |
| Mark Ansermino anserminos@yahoo.ca British Columbia Mark Ansermino Biography |
The University of British Columbia |
|
Professor | Director of the Centre for International Child Health at British Columbia's Children's Hospital. Co-lead (with Prof Tex Kissoon) of the Pediatric Sepsis Data CoLab. |
| Gedas Cepinskas gcepinsk@uwo.ca 519-685-8500 ext 55073 Ontario Lawson Health Research Institute - Critical Illness |
Lawson Health Research Institute |
|
Scientist/Program Director | While our Program (Centre for Critical Illness Research at Lawson HRI-established in 1994 to investigate pathogenesis of organ dysfunction in sepsis and other systemic disorders) does not directly investigates the roles of diabetes mellitus and glucose control have on outcomes in patients with sepsis, we, however, have strong expertise in animal model(s) of diabetes and are well positioned to address "diabetes-sepsis" research axis in pre-clinical models. In addition, well-recognized "Diabetes Research Group" in London, ON is available for immediate collaborative work. Finally, we have strong clinical team (lead by Dr. Claudio Martin; Critical Care Medicine) with a long-lasting commitment in clinical sepsis research. |
| Monica Gorassini monica.gorassini@ualberta.ca 7804922463 Alberta University of Alberta - Motor Control Labratory |
University of Alberta |
|
Professor | I work in the motoneuron field and I am collaborating with Dr. Mark Rich from Wright State University on the role of motoneurons in ICU acquired weakness. Mark (working with Tim Cope) has a rodent model of sepsis and has found that a decrease in persistent sodium channel activation prevents the motoneuron from firing properly, contributing to muscle weakness (see Nardelli et al., Ann Neurol 82: 961-971, 2017). I would like to record single motor unit activity in patients with ICU weakness using non-invasive, multi-electrode surface EMG arrays to determine if a similar problem with motoneuron recruitment and firing behaviour exists in humans. If you think this type of project would fit in well with your application, please contact me to discuss. Monica Gorassini (monica.gorassini@ualberta.ca), Edmonton, AB. |
| Niranjan Kissoon Nkissoon@cw.bc.ca 604 875 2507 British Columbia |
University of British Columbia |
|
Professor | |
| Ivan ibrukner@jgh.mcgill.ca 1 514 8038782 Quebec |
OPTILAB |
|
Technical Lab Co-Director | We are specially interested in novel technological platforms of direct from plasma NGS universal pathogen discovery/identification. We have strong collaboration with CompleteGenomics-BGI (USA-China) techno company with is emerging as attractive option over illumina and/or Ion Torrent technology. The Karius Inc is USA version of this "service" however, the price and accuracy of plasma/serum screening of 200 "blood cultures" per day (our hospital) will be facilitated by this approach, specially with goring segment of immunocompromised diabetic patients, where use of "state of the art" molecular tests with pre-defined list of pathogens is not good enough to cover 30-50% of unresolved cases. Turn Arrount Time within 24-48h... |
| Janos G Filep janos.g.filep@umontreal.ca 514 0252-3400 ext 4662 Quebec Janos G Filep Biography |
University of Montreal |
|
Professor | Leukocyte biology (activation, apoptosis, efferocytosis) Endothelial cell biology Resolution of inflammation |
| Manish Sadarangani msadarangani@bcchr.ubc.ca British Columbia Vaccine Evaluation Center |
University of British Columbia |
|
Assistant Professor | Director, Vaccine Evaluation Center, BC Children's Hospital Research Institute |
| Liam Brunham liam.brunham@ubc.ca British Columbia Centre for Heart Lung Innovation |
UBC |
|
Assistant Professor | Our research focuses on the intersection of metabolism with pathogenesis of sepsis, early detection, and clinical outcomes. We have identified a number of mechanisms involved in lipid metabolism that significantly influence important clinical outcomes in sepsis, represent novel biomarkers for early detection and risk stratification, and may lead to new targets for therapies. |
| Christian Lehmann chlehmann@dal.ca 9024523813 Nova Scotia Dalhousie University |
Dalhousie University |
|
Professor | CIHR themes/potential contributions: Biomedical: Experimental research on novel pharmacological approaches for the treatment of sepsis with a special focus on intravital imaging of the immune response in sepsis. Recently, our group published a comprehensive experimental study on the impact of insulin on the intestinal microcirculation in a model of sepsis-related hyperglycemia (Microvasc Res, 2018). Clinical: Intravital imaging of the immune response has a great potential to be utilized for human studies in sepsis (see Lehmann C, Clin Hemorheol Microcirc, 2018). |
| Pascal Lavoie plavoie@cw.bc.ca 604-875-2135 British Columbia Pascal Lavoie Biography |
BC Children's Hospital Research Institute |
|
Clinician-Scientist, Associate Professor | N/A |
| Sabah Hussain sabah.hussain@muhc.mcgill.ca 514 843 1664 Quebec McGill University Health Centre |
McGill University Health Centre |
|
Professor | I study the mechanisms and prevention of skeletal muscle dysfunction in sepsis over the past 25 years |
| Liisa Holsti liisa.holsti@ubc.ca 604-875 2000 ext 5200 British Columbia UBC - Faculty of Medicine |
UBC |
|
Associate Professor | I am developing a new outcome tool to measure the neurodevelopmental impact of sepsis in children. |
| Anthony Shaw Anthony.Shaw@nrc-cnrc.gc.ca 204-984-4626 Manitoba NRC - Medical Research Centre |
NRC Winnipeg |
|
Research Officer | Expertise in metabolic fingerprinting via infrared spectroscopy in particular. Strong interest in unlocking the potential for this approach for sepsis diagnosis and prognosis. |
| Richard Schulz richard.schulz@ualberta.ca 780-492-6581 Alberta Richard Schulz Biography |
University of Alberta |
|
Professor | I have an active interest and research background in understanding the roles of nitric oxide, peroxynitrite and matrix metallproteinases in cardiac and vascular dysfunction in sepsis. |
| Melissa Parker parkermj@mcmaster.ca Melissa J. Parker, McMaster University, Department of Pediatrics |
McMaster University |
|
Associate Professor of Pediatrics, McMaster University | Clinician-Scientist trained in Pediatric Emergency Medicine, Critical Care Medicine and Clinical Research Methods with research focus in pediatric sepsis resuscitation. Clinical trialist with translational and qualitative research collaborations. |
- Date modified: